Protalix Biotherapeutics Stock Technical Analysis
PLX Stock | USD 1.25 0.03 2.46% |
As of the 28th of March, Protalix Biotherapeutics holds the Risk Adjusted Performance of (0.07), coefficient of variation of (685.10), and Variance of 9.97. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Protalix Biotherapeutics, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down and interpolate thirteen technical drivers for Protalix Biotherapeutics, which can be compared to its competitors. Please check Protalix Biotherapeutics market risk adjusted performance and treynor ratio to decide if Protalix Biotherapeutics is priced some-what accurately, providing market reflects its current price of 1.25 per share. Given that Protalix Biotherapeutics is a hitting penny stock territory we advise to closely look at its jensen alpha.
Protalix Biotherapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Protalix, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ProtalixProtalix |
Protalix Biotherapeutics Analyst Consensus
Target Price | Advice | # of Analysts | |
16.0 | Buy | 1 | Odds |
Most Protalix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Protalix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Protalix Biotherapeutics, talking to its executives and customers, or listening to Protalix conference calls.
Protalix Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Protalix Biotherapeutics Technical Analysis
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Protalix Biotherapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Protalix Biotherapeutics Trend Analysis
Use this graph to draw trend lines for Protalix Biotherapeutics. You can use it to identify possible trend reversals for Protalix Biotherapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Protalix Biotherapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Protalix Biotherapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Protalix Biotherapeutics applied against its price change over selected period. The best fit line has a slop of 0.0062 , which may imply that the returns on investment in Protalix Biotherapeutics will continue to fail. It has 122 observation points and a regression sum of squares at 1.47, which is the sum of squared deviations for the predicted Protalix Biotherapeutics price change compared to its average price change.About Protalix Biotherapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Protalix Biotherapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Protalix Biotherapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Protalix Biotherapeutics price pattern first instead of the macroeconomic environment surrounding Protalix Biotherapeutics. By analyzing Protalix Biotherapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Protalix Biotherapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Protalix Biotherapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
2021 | 2022 | 2023 | 2024 (projected) | Days Of Sales Outstanding | 32.76 | 35.14 | 29.38 | 27.91 | Days Of Inventory Outstanding | 400.83 | 313.06 | 302.47 | 366.4 |
Protalix Biotherapeutics March 28, 2024 Technical Indicators
Most technical analysis of Protalix help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Protalix from various momentum indicators to cycle indicators. When you analyze Protalix charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.07) | |||
Market Risk Adjusted Performance | 8.54 | |||
Mean Deviation | 2.57 | |||
Coefficient Of Variation | (685.10) | |||
Standard Deviation | 3.16 | |||
Variance | 9.97 | |||
Information Ratio | (0.19) | |||
Jensen Alpha | (0.46) | |||
Total Risk Alpha | (1.18) | |||
Treynor Ratio | 8.53 | |||
Maximum Drawdown | 16.16 | |||
Value At Risk | (4.55) | |||
Potential Upside | 4.7 | |||
Skewness | 0.0722 | |||
Kurtosis | 0.1086 |
Protalix Biotherapeutics March 28, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Protalix stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 17,728 | ||
Daily Balance Of Power | 0.50 | ||
Rate Of Daily Change | 1.02 | ||
Day Median Price | 1.25 | ||
Day Typical Price | 1.25 | ||
Price Action Indicator | 0.02 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protalix Biotherapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Protalix Stock please use our How to Invest in Protalix Biotherapeutics guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Protalix Stock analysis
When running Protalix Biotherapeutics' price analysis, check to measure Protalix Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protalix Biotherapeutics is operating at the current time. Most of Protalix Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Protalix Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protalix Biotherapeutics' price. Additionally, you may evaluate how the addition of Protalix Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Protalix Biotherapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protalix Biotherapeutics. If investors know Protalix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protalix Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.39) | Earnings Share 0.09 | Revenue Per Share 0.97 | Quarterly Revenue Growth 0.217 | Return On Assets 0.0933 |
The market value of Protalix Biotherapeutics is measured differently than its book value, which is the value of Protalix that is recorded on the company's balance sheet. Investors also form their own opinion of Protalix Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protalix Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protalix Biotherapeutics' market value can be influenced by many factors that don't directly affect Protalix Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protalix Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protalix Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protalix Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.